Matches in Wikidata for { <http://www.wikidata.org/entity/Q67126213> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- Q67126213 description "clinical trial" @default.
- Q67126213 description "ensayu clínicu" @default.
- Q67126213 description "klinisch onderzoek" @default.
- Q67126213 description "клінічне випробування" @default.
- Q67126213 name "Evaluation of the Efficacy and Safety of QVA149 (110/50 μg o.d.) vs Tiotropium (18 µg o.d.) + Salmeterol/Fluticasone Propionate FDC (50/500 µg b.i.d.) in Patients With Moderate to Severe COPD" @default.
- Q67126213 name "Evaluation of the Efficacy and Safety of QVA149" @default.
- Q67126213 type Item @default.
- Q67126213 label "Evaluation of the Efficacy and Safety of QVA149 (110/50 μg o.d.) vs Tiotropium (18 µg o.d.) + Salmeterol/Fluticasone Propionate FDC (50/500 µg b.i.d.) in Patients With Moderate to Severe COPD" @default.
- Q67126213 label "Evaluation of the Efficacy and Safety of QVA149" @default.
- Q67126213 prefLabel "Evaluation of the Efficacy and Safety of QVA149 (110/50 μg o.d.) vs Tiotropium (18 µg o.d.) + Salmeterol/Fluticasone Propionate FDC (50/500 µg b.i.d.) in Patients With Moderate to Severe COPD" @default.
- Q67126213 prefLabel "Evaluation of the Efficacy and Safety of QVA149" @default.
- Q67126213 P1132 Q67126213-6D2CDDDE-81F4-4533-9B61-3546670A2B54 @default.
- Q67126213 P1476 Q67126213-FECF943D-1208-4727-9A5D-72D06495CA7B @default.
- Q67126213 P17 Q67126213-007497B8-CB4C-4FD6-939B-EB9A2DB53657 @default.
- Q67126213 P17 Q67126213-06B15F4F-071D-4EFE-A635-361FBA67CEC0 @default.
- Q67126213 P17 Q67126213-0A1007EF-3323-4586-B6B1-D95C10CD6985 @default.
- Q67126213 P17 Q67126213-0AD476EF-9257-49B8-8823-ECDE93E6302A @default.
- Q67126213 P17 Q67126213-295AC5E8-936D-4CC2-99A2-2DAD285EDE8A @default.
- Q67126213 P17 Q67126213-2DF056CC-25F1-4CB3-AAF9-AF9438FB6877 @default.
- Q67126213 P17 Q67126213-45D42F83-C177-4D11-A2BB-F42129682583 @default.
- Q67126213 P17 Q67126213-4FB68B46-6445-4361-B092-7AABACEED703 @default.
- Q67126213 P17 Q67126213-50E68FCA-1D88-4F9F-AD8B-B2D10AD7E57C @default.
- Q67126213 P17 Q67126213-6D6C2E09-1DC2-4338-A4EE-47A086E7BBDB @default.
- Q67126213 P17 Q67126213-800BCAD7-190D-4F76-BB78-A3F7391A39C3 @default.
- Q67126213 P17 Q67126213-978C6322-5E12-46DC-BE60-313022008A64 @default.
- Q67126213 P17 Q67126213-9D54E157-E03C-49D6-8EF0-4061A20E64F5 @default.
- Q67126213 P17 Q67126213-A2A5192D-72D0-4611-B61C-A32BCACD5F4A @default.
- Q67126213 P17 Q67126213-B0377418-CE55-44D3-8DD2-A945B38DF07D @default.
- Q67126213 P17 Q67126213-B64138E9-7592-4949-A017-C6DC60E5189A @default.
- Q67126213 P17 Q67126213-BA4043BB-BA6B-4AFA-B6B0-E4A785D5C022 @default.
- Q67126213 P17 Q67126213-BF83708F-A9D5-4C5C-AE6D-1293553948AB @default.
- Q67126213 P17 Q67126213-E802A2CB-4C6B-4981-AA86-8CE986970D23 @default.
- Q67126213 P17 Q67126213-E8ABF24C-9258-4829-BD3A-1DBCBCD87413 @default.
- Q67126213 P2899 Q67126213-1056AE4E-7474-4259-92B2-389FA48E42BA @default.
- Q67126213 P3098 Q67126213-0BCB437B-115D-497D-92D0-FCDE3B3025A6 @default.
- Q67126213 P31 Q67126213-C125AC4B-E298-401D-9BAB-59EFB81A0948 @default.
- Q67126213 P4844 Q67126213-6CC81AE5-7494-452F-83F2-E7FBA26EFC74 @default.
- Q67126213 P4844 Q67126213-7C1C1738-B35C-4678-91B8-033BC6FCF4E2 @default.
- Q67126213 P580 Q67126213-77C41C04-8AAB-4899-9236-EEAD08332290 @default.
- Q67126213 P582 Q67126213-1B22F956-E80A-4956-8819-DE23E77A7FC1 @default.
- Q67126213 P6099 Q67126213-F0E11F1A-137B-4302-92E4-983CC7E595B6 @default.
- Q67126213 P8363 Q67126213-50AB08E3-AD4B-4D15-90ED-29D2DD047F25 @default.
- Q67126213 P859 Q67126213-E4ADE08D-88C6-4FBD-8563-D55C386898F9 @default.
- Q67126213 P1132 "+1053" @default.
- Q67126213 P1476 "A 26-week, Randomized, Double Blind, Parallel-group Multicenter Study to Assess the Efficacy and Safety of QVA149 (110/50 μg o.d.) vs Tiotropium (18 µg o.d.) + Salmeterol/Fluticasone Propionate FDC (50/500 µg b.i.d.) in Patients With Moderate to Severe COPD" @default.
- Q67126213 P17 Q145 @default.
- Q67126213 P17 Q16 @default.
- Q67126213 P17 Q183 @default.
- Q67126213 P17 Q191 @default.
- Q67126213 P17 Q211 @default.
- Q67126213 P17 Q214 @default.
- Q67126213 P17 Q218 @default.
- Q67126213 P17 Q219 @default.
- Q67126213 P17 Q224 @default.
- Q67126213 P17 Q28 @default.
- Q67126213 P17 Q29 @default.
- Q67126213 P17 Q31 @default.
- Q67126213 P17 Q35 @default.
- Q67126213 P17 Q36 @default.
- Q67126213 P17 Q37 @default.
- Q67126213 P17 Q40 @default.
- Q67126213 P17 Q403 @default.
- Q67126213 P17 Q41 @default.
- Q67126213 P17 Q414 @default.
- Q67126213 P17 Q55 @default.
- Q67126213 P2899 "+40" @default.
- Q67126213 P3098 "NCT02603393" @default.
- Q67126213 P31 Q30612 @default.
- Q67126213 P4844 Q27264747 @default.
- Q67126213 P4844 Q411917 @default.
- Q67126213 P580 "2015-11-20T00:00:00Z" @default.
- Q67126213 P582 "2017-07-18T00:00:00Z" @default.
- Q67126213 P6099 Q42825046 @default.
- Q67126213 P8363 Q78089383 @default.
- Q67126213 P859 Q507154 @default.